NASDAQ: IBEXIbex Ltd Stock
$14.70+0.19 (+1.31%)
Updated Sep 20, 2023
IBEX Price
$14.70
Fair Value Price
N/A
Market Cap
$268.98M
52 Week Low
$11.45
52 Week High
$31.40
P/E
8.45x
P/B
1.79x
P/S
0.74x
PEG
N/A
Dividend Yield
N/A
Revenue
$523.12M
Earnings
$31.58M
Gross Margin
28.3%
Operating Margin
7.74%
Profit Margin
6%
Debt to Equity
0.96
Operating Cash Flow
$42M
Beta
0.64
Next Earnings
Nov 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A
IBEX Overview
IBEX Limited's Customer Lifecycle Experience platform providing solutions that span the customer lifecycle. Solutions include ibex Digital, ibex Connect, and ibex CX. Its technologies include AdCast AI, BundleDealer, CoPilot, Control Tower, Witness, and RefleCX. IBEX serves the banking and financial services, delivery and logistics, retail and e-commerce, healthcare, technology, streaming and entertainment, travel and hospitality, and utilities sectors. IBEX was incorporated in 2017 and is headquartered in Washington, DC.
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IBEX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IBEX is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IBEX is good value based on its earnings relative to its share price (8.45x), compared to the US market average (14.54x)
P/E vs Market Valuation
IBEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more IBEX due diligence checks available for Premium users.
Be the first to know about important IBEX news, forecast changes, insider trades & much more!
IBEX News
Valuation
IBEX fair value
Fair Value of IBEX stock based on Discounted Cash Flow (DCF)
Price
$14.70
Fair Value
$15.57
Undervalued by
5.58%
IBEX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
IBEX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
8.45x
Industry
31.47x
Market
14.54x
IBEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IBEX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
IBEX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.79x
Industry
4.23x
IBEX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IBEX's financial health
Profit margin
Revenue
$124.3M
Net Income
$13.7M
Profit Margin
11%
IBEX's Earnings (EBIT) of $40.48M... subscribe to Premium to read more.
Interest Coverage Financials
IBEX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$293.3M
Liabilities
$143.4M
Debt to equity
0.96
IBEX's short-term assets ($158.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IBEX's short-term assets ($158.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IBEX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IBEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$7.6M
Investing
-$4.3M
Financing
$10.3M
IBEX's operating cash flow ($41.86M)... subscribe to Premium to read more.
Debt Coverage Financials
IBEX vs Information Technology Service Stocks
Ibex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.